For Patients For Caregivers For Medical Professionals

HELPLINE 1-800-465-4837
Mon-Fri 9am – 5pm EST

11 MARCH 2019

ALF Welcomes New Members to Corporate Council

The American Liver Foundation’s work is made possible by a diverse group of supporters.  Individuals whose lives and hearts have been touched in some way by liver disease are by far the most numerous.  We also depend on foundation funding and we are working hard to increase it.  Finally, we receive contributions from corporations that support our vision of a world without liver disease.

Some of these corporations have become part ALF’s Corporate Council.  The growing number of members represent a prestigious group of companies that shares our commitment to building a healthier nation.  We are excited to work with them to discover where our joint efforts can take us.  We are pleased to announce the newest 2019 Gold Level members of our Corporate Council.

Allergan has joined the Corporate Council as a Gold level member.  The Allergan Foundation has also provided a grant to ALF to produce a series of educational videos on nonalcoholic steatohepatitis (NASH), which will be released in March.

Exelixis renewed its Gold level membership on the same day as the U.S. Food and Drug Administration (FDA) approved CABOMETYX® (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.  It was wonderful day for those fighting to end liver disease.

Mallinckrodt Pharmaceuticals renewed its membership and expanded its relationship with ALF by enabling us to raise greater awareness about hepatorenal, a rare, life-threatening disease with an estimated prevalence of greater than 22,000 diagnosed in the U.S. each year.

ALF Corporate Council members provide financial assistance in support of ALF’s mission and come together annually to learn more about ALF and develop strategies to collaborate on common goals, such as ending the stigma of liver disease. For a complete list of ALF Corporate Council Member, please click on the link:

Tom Nealon
President & CEO
American Liver Foundation

Share this page

Comments are closed.